Tsai HL, Huang CW, Lin YW, Wang JH, et al. Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST). Eur J Cancer 2020;138:19-29.
PMID: 32829105